A functional analysis of intestinal microbiota affected with intestinal IgA antibody in the inflammatory bowel disease.

Not Applicable

Recruiting

• Conditions: lcerative colitis

• Registration Number: JPRN-UMIN000024638
• Lead Sponsor: ara Institute of Science and Technology

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-11-01
• Study Completion: 2021-03-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Not provided

Exclusion Criteria

1. That took antibiotics within four weeks from time of the sampling or has been put on a drip. 2. Pregnant women. 3. Fulminant ulcerative colitis.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
We can confirm that enterocolitis depression effect by the intestinal bacterial flora control of the observed W27 antibody occurs in a mouse for the intestinal bacterial flora of the patients of the human. It can become the data base to apply an IgA antibody to human in the future to ascertain the target which the intestinal IgA antibody of the human recognizes.